RegenXBio (RGNX)
NASDAQ:RGNX
Holding RGNX?
Track your performance easily

RegenXBio (RGNX) Financial Statements

816 Followers

RegenXBio Financial Overview

RegenXBio's market cap is currently ―. The company's EPS TTM is $-5.269; its P/E ratio is -1.77; RegenXBio is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-1.12. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 22.30M$ 15.62M$ 22.21M$ 28.91M$ 19.98M
Gross Profit$ 11.72M$ 11.34M$ 10.97M$ 16.53M$ 10.53M
EBIT$ -52.54M$ -61.43M$ -61.68M$ -60.24M$ -70.94M
EBITDA$ -48.02M$ -57.72M$ -57.34M$ -56.01M$ -66.13M
Net Income Common Stockholders$ -52.99M$ -63.33M$ -62.89M$ -61.43M$ -72.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 290.36M$ 338.70M$ 275.26M$ 301.89M$ 320.08M
Total Assets$ 569.38M$ 629.22M$ 573.97M$ 633.79M$ 682.46M
Total Debt$ 85.54M$ 87.25M$ 89.29M$ 90.70M$ 91.58M
Net Debt$ -204.82M$ -251.45M$ -185.97M$ -211.19M$ -228.50M
Total Liabilities$ 221.11M$ 238.55M$ 262.23M$ 270.69M$ 276.60M
Stockholders Equity$ 348.23M$ 390.67M$ 311.74M$ 363.10M$ 405.85M
Cash Flow-
Free Cash Flow$ -45.97M$ -56.01M$ -41.89M$ -50.85M$ -49.90M
Operating Cash Flow$ -45.50M$ -55.45M$ -40.76M$ -49.41M$ -47.32M
Investing Cash Flow$ -268.00K$ 13.18M$ 33.97M$ 38.66M$ 55.22M
Financing Cash Flow$ -9.45M$ 120.72M$ -11.96M$ -4.80M$ -9.16M
Currency in USD

RegenXBio Earnings and Revenue History

RegenXBio Debt to Assets

RegenXBio Cash Flow

RegenXBio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis